Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Buffett's Berkshire buys Suncor, Dish as stock bet grows

Thu, 15th Aug 2013 16:59

* Berkshire adds to Wells Fargo, GM; slashes Kraft, Mondelez

* Some investments kept confidential

* Suncor shares rise after Berkshire reveals stake

By Jonathan Stempel and Tanya Agrawal

Aug 15 (Reuters) - Berkshire Hathaway Inc reported new stakes in Suncor Energy Inc and DishNetwork Corp as the company run by Warren Buffett addedbillions of dollars of stock investments.

The changes were disclosed in a U.S. Securities and ExchangeCommission filing made public on Thursday, which detailed $89billion of Berkshire equity investments, mostly listed on U.S.exchanges, as of June 30.

U.S. regulators require large investors to disclose theirstock holdings every quarter, and the disclosures can offer awindow into their strategies for buying and selling stocks.

Berkshire took a 17.8 million-share stake in Calgary-basedSuncor, which is Canada's biggest oil and gas producer and has alarge presence in the Alberta oil sands. That stake was valuedat $524 million at the end of the second quarter.

It also reported a small, 547,312-share stake in Dish, thesatellite TV company run by billionaire Charlie Ergen, valued at$23.3 million on June 30.

Suncor spokeswoman Kelli Stevens declined to comment, sayingthe company does not typically discuss individual investors'holdings. Dish spokesman Bob Toevs also declined to comment.

Shares of companies often rise after Berkshire disclosessizable new investments because investors try to copy Buffett,the world's fourth-richest person according to Forbes magazine.

In afternoon trading, Suncor shares were up 68 cents, or 2percent, at C$34.47. Dish shares were down 29 cents at $44.47.

David McColl, a Morningstar Inc equity analyst in Chicago,said a shortage of pipelines has forced Suncor and rivals tomove more products by rail, but that Suncor has indicated anability to address this problem in the next one to five years.

"Suncor is one of the most heavily undervalued Canadianintegrated oil producers," he said. "It is no surprise that avalue investor like Berkshire Hathaway would view it as aphenomenal investment opportunity."

Berkshire has benefited this year from Buffett's preferencefor investments in businesses and stocks over fixed income,which has been under pressure from rising interest rates.

The Omaha, Nebraska-based company's book value per share,Buffett's preferred measure of growth, grew 7.6 percent fromJanuary to June.

Its largest stock holding, Wells Fargo & Co, grew1.1 percent in the second quarter to 463.1 million shares, equalto a $19.1 billion stake in the fourth-largest U.S. bank.

CONFIDENTIAL TREATMENT

Berkshire spent $4.64 billion on stocks in the quarter. While Buffett has said he makes Berkshire's largest investments,some investments are made by portfolio managers Todd Combs andTed Weschler, who oversee several billion dollars each.

Thursday's filing did not say who bought what, but said thatsome holdings were reported confidentially to the SEC.

Buffett sometimes gets SEC permission to amass big positionsquietly so he need not worry about copycat investors. One ofBerkshire's top holdings, a $13 billion stake in InternationalBusiness Machines Corp, was built in this manner.

Earlier this month, Berkshire said it ended June with $101.9billion of equity securities overall. Its top four holdings -Wells Fargo, Coca-Cola Co, IBM and American Express Co - were worth more than $59 billion as of June 30.

Berkshire also owns more than 80 businesses in such areas asinsurance, railroads, utilities, chemicals, apparel and food.

In recent months, it bought half of ketchup maker H.J. HeinzCo and made several smaller acquisitions.

On Wednesday, its HomeServices of America Inc unit, thesecond-largest U.S. full-service residential real estatebrokerage, said it bought real estate service companiesPrudential Fox & Roach and Trident Group for undisclosed prices.

KRAFT, MONDELEZ SLASHED

During the quarter, Berkshire added to stakes in Bank of NewYork Mellon Corp, automaker General Motors Co,oilfield equipment provider National Oilwell Varco Inc,US Bancorp and Verisign Inc, which assignsInternet protocol addresses. The GM share stake grew 60 percent.

Berkshire slashed its stakes in food companies Kraft FoodsGroup Inc and Mondelez International Inc by 88percent and 92 percent, respectively, and shed its stake innewspaper and broadcasting company Gannett Co.

It also reported lower stakes in drugmaker GlaxoSmithKlinePlc and credit rating company Moody's Corp.

The SEC filing was to have been made public on Wednesday,but the release was delayed by a glitch in the regulator'sfiling system. An assistant to Buffett said Berkshire submittedthe filing prior to Wednesday's deadline.

In afternoon trading, Berkshire's Class A shares were down1.2 percent at $172,711, and its Class B shares were down 1.3percent at $115.08.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.